Global Antisense and RNAi Therapeutics Drug Market Growth (Status and Outlook) 2026-2032
The global Antisense and RNAi Therapeutics Drug market size is predicted to grow from US$ 948 million in 2025 to US$ 1460 million in 2032; it is expected to grow at a CAGR of 6.5% from 2026 to 2032.
Many pharmaceutical companies were conducting research on oligonucleotide therapy, which employs chemically synthesized nucleotide-like small molecule drugs with potential specificity similar to that of therapeutic antibodies.
United States market for Antisense and RNAi Therapeutics Drug is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Antisense and RNAi Therapeutics Drug is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Antisense and RNAi Therapeutics Drug is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Antisense and RNAi Therapeutics Drug players cover Biogen, Sarepta Therapeutics, Jazz Pharmaceuticals, Bausch & Lomb, Alnylam Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?Antisense and RNAi Therapeutics Drug Industry Forecast? looks at past sales and reviews total world Antisense and RNAi Therapeutics Drug sales in 2025, providing a comprehensive analysis by region and market sector of projected Antisense and RNAi Therapeutics Drug sales for 2026 through 2032. With Antisense and RNAi Therapeutics Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antisense and RNAi Therapeutics Drug industry.
This Insight Report provides a comprehensive analysis of the global Antisense and RNAi Therapeutics Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Antisense and RNAi Therapeutics Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Antisense and RNAi Therapeutics Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antisense and RNAi Therapeutics Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antisense and RNAi Therapeutics Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Antisense and RNAi Therapeutics Drug market by product type, application, key players and key regions and countries.
Segmentation by Type:
Many pharmaceutical companies were conducting research on oligonucleotide therapy, which employs chemically synthesized nucleotide-like small molecule drugs with potential specificity similar to that of therapeutic antibodies.
United States market for Antisense and RNAi Therapeutics Drug is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Antisense and RNAi Therapeutics Drug is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Antisense and RNAi Therapeutics Drug is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Antisense and RNAi Therapeutics Drug players cover Biogen, Sarepta Therapeutics, Jazz Pharmaceuticals, Bausch & Lomb, Alnylam Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?Antisense and RNAi Therapeutics Drug Industry Forecast? looks at past sales and reviews total world Antisense and RNAi Therapeutics Drug sales in 2025, providing a comprehensive analysis by region and market sector of projected Antisense and RNAi Therapeutics Drug sales for 2026 through 2032. With Antisense and RNAi Therapeutics Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antisense and RNAi Therapeutics Drug industry.
This Insight Report provides a comprehensive analysis of the global Antisense and RNAi Therapeutics Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Antisense and RNAi Therapeutics Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Antisense and RNAi Therapeutics Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antisense and RNAi Therapeutics Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antisense and RNAi Therapeutics Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Antisense and RNAi Therapeutics Drug market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Antisense Oligonucleotide
- Aptamer
- Other
- Neuromuscular Diseases
- ATTR
- Hepatic VOD
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Biogen
- Sarepta Therapeutics
- Jazz Pharmaceuticals
- Bausch & Lomb
- Alnylam Pharmaceuticals
- Dynavax Technologies
- Kastle therapeutics
- Akcea Therapeutics
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Antisense and RNAi Therapeutics Drug Market Size (2021-2032)
2.1.2 Antisense and RNAi Therapeutics Drug Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Antisense and RNAi Therapeutics Drug by Country/Region (2021, 2025 & 2032)
2.2 Antisense and RNAi Therapeutics Drug Segment by Type
2.2.1 Antisense Oligonucleotide
2.2.2 Aptamer
2.2.3 Other
2.2.4 Antisense and RNAi Therapeutics Drug Market Size by Type
2.2.4.1 Antisense and RNAi Therapeutics Drug Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Antisense and RNAi Therapeutics Drug Market Size Market Share by Type (2021-2026)
2.3 Antisense and RNAi Therapeutics Drug Segment by Application
2.3.1 Neuromuscular Diseases
2.3.2 ATTR
2.3.3 Hepatic VOD
2.3.4 Other
2.3.5 Antisense and RNAi Therapeutics Drug Market Size by Application
2.3.5.1 Antisense and RNAi Therapeutics Drug Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.5.2 Global Antisense and RNAi Therapeutics Drug Market Size Market Share by Application (2021-2026)
3 ANTISENSE AND RNAI THERAPEUTICS DRUG MARKET SIZE BY PLAYER
3.1 Antisense and RNAi Therapeutics Drug Market Size Market Share by Player
3.1.1 Global Antisense and RNAi Therapeutics Drug Revenue by Player (2021-2026)
3.1.2 Global Antisense and RNAi Therapeutics Drug Revenue Market Share by Player (2021-2026)
3.2 Global Antisense and RNAi Therapeutics Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ANTISENSE AND RNAI THERAPEUTICS DRUG BY REGION
4.1 Antisense and RNAi Therapeutics Drug Market Size by Region (2021-2026)
4.2 Global Antisense and RNAi Therapeutics Drug Annual Revenue by Country/Region (2021-2026)
4.3 Americas Antisense and RNAi Therapeutics Drug Market Size Growth (2021-2026)
4.4 APAC Antisense and RNAi Therapeutics Drug Market Size Growth (2021-2026)
4.5 Europe Antisense and RNAi Therapeutics Drug Market Size Growth (2021-2026)
4.6 Middle East & Africa Antisense and RNAi Therapeutics Drug Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Antisense and RNAi Therapeutics Drug Market Size by Country (2021-2026)
5.2 Americas Antisense and RNAi Therapeutics Drug Market Size by Type (2021-2026)
5.3 Americas Antisense and RNAi Therapeutics Drug Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antisense and RNAi Therapeutics Drug Market Size by Region (2021-2026)
6.2 APAC Antisense and RNAi Therapeutics Drug Market Size by Type (2021-2026)
6.3 APAC Antisense and RNAi Therapeutics Drug Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Antisense and RNAi Therapeutics Drug Market Size by Country (2021-2026)
7.2 Europe Antisense and RNAi Therapeutics Drug Market Size by Type (2021-2026)
7.3 Europe Antisense and RNAi Therapeutics Drug Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Antisense and RNAi Therapeutics Drug by Region (2021-2026)
8.2 Middle East & Africa Antisense and RNAi Therapeutics Drug Market Size by Type (2021-2026)
8.3 Middle East & Africa Antisense and RNAi Therapeutics Drug Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ANTISENSE AND RNAI THERAPEUTICS DRUG MARKET FORECAST
10.1 Global Antisense and RNAi Therapeutics Drug Forecast by Region (2027-2032)
10.1.1 Global Antisense and RNAi Therapeutics Drug Forecast by Region (2027-2032)
10.1.2 Americas Antisense and RNAi Therapeutics Drug Forecast
10.1.3 APAC Antisense and RNAi Therapeutics Drug Forecast
10.1.4 Europe Antisense and RNAi Therapeutics Drug Forecast
10.1.5 Middle East & Africa Antisense and RNAi Therapeutics Drug Forecast
10.2 Americas Antisense and RNAi Therapeutics Drug Forecast by Country (2027-2032)
10.2.1 United States Market Antisense and RNAi Therapeutics Drug Forecast
10.2.2 Canada Market Antisense and RNAi Therapeutics Drug Forecast
10.2.3 Mexico Market Antisense and RNAi Therapeutics Drug Forecast
10.2.4 Brazil Market Antisense and RNAi Therapeutics Drug Forecast
10.3 APAC Antisense and RNAi Therapeutics Drug Forecast by Region (2027-2032)
10.3.1 China Antisense and RNAi Therapeutics Drug Market Forecast
10.3.2 Japan Market Antisense and RNAi Therapeutics Drug Forecast
10.3.3 Korea Market Antisense and RNAi Therapeutics Drug Forecast
10.3.4 Southeast Asia Market Antisense and RNAi Therapeutics Drug Forecast
10.3.5 India Market Antisense and RNAi Therapeutics Drug Forecast
10.3.6 Australia Market Antisense and RNAi Therapeutics Drug Forecast
10.4 Europe Antisense and RNAi Therapeutics Drug Forecast by Country (2027-2032)
10.4.1 Germany Market Antisense and RNAi Therapeutics Drug Forecast
10.4.2 France Market Antisense and RNAi Therapeutics Drug Forecast
10.4.3 UK Market Antisense and RNAi Therapeutics Drug Forecast
10.4.4 Italy Market Antisense and RNAi Therapeutics Drug Forecast
10.4.5 Russia Market Antisense and RNAi Therapeutics Drug Forecast
10.5 Middle East & Africa Antisense and RNAi Therapeutics Drug Forecast by Region (2027-2032)
10.5.1 Egypt Market Antisense and RNAi Therapeutics Drug Forecast
10.5.2 South Africa Market Antisense and RNAi Therapeutics Drug Forecast
10.5.3 Israel Market Antisense and RNAi Therapeutics Drug Forecast
10.5.4 Turkey Market Antisense and RNAi Therapeutics Drug Forecast
10.6 Global Antisense and RNAi Therapeutics Drug Forecast by Type (2027-2032)
10.7 Global Antisense and RNAi Therapeutics Drug Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Antisense and RNAi Therapeutics Drug Forecast
11 KEY PLAYERS ANALYSIS
11.1 Biogen
11.1.1 Biogen Company Information
11.1.2 Biogen Antisense and RNAi Therapeutics Drug Product Offered
11.1.3 Biogen Antisense and RNAi Therapeutics Drug Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Biogen Main Business Overview
11.1.5 Biogen Latest Developments
11.2 Sarepta Therapeutics
11.2.1 Sarepta Therapeutics Company Information
11.2.2 Sarepta Therapeutics Antisense and RNAi Therapeutics Drug Product Offered
11.2.3 Sarepta Therapeutics Antisense and RNAi Therapeutics Drug Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Sarepta Therapeutics Main Business Overview
11.2.5 Sarepta Therapeutics Latest Developments
11.3 Jazz Pharmaceuticals
11.3.1 Jazz Pharmaceuticals Company Information
11.3.2 Jazz Pharmaceuticals Antisense and RNAi Therapeutics Drug Product Offered
11.3.3 Jazz Pharmaceuticals Antisense and RNAi Therapeutics Drug Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Jazz Pharmaceuticals Main Business Overview
11.3.5 Jazz Pharmaceuticals Latest Developments
11.4 Bausch & Lomb
11.4.1 Bausch & Lomb Company Information
11.4.2 Bausch & Lomb Antisense and RNAi Therapeutics Drug Product Offered
11.4.3 Bausch & Lomb Antisense and RNAi Therapeutics Drug Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Bausch & Lomb Main Business Overview
11.4.5 Bausch & Lomb Latest Developments
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Information
11.5.2 Alnylam Pharmaceuticals Antisense and RNAi Therapeutics Drug Product Offered
11.5.3 Alnylam Pharmaceuticals Antisense and RNAi Therapeutics Drug Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Alnylam Pharmaceuticals Main Business Overview
11.5.5 Alnylam Pharmaceuticals Latest Developments
11.6 Dynavax Technologies
11.6.1 Dynavax Technologies Company Information
11.6.2 Dynavax Technologies Antisense and RNAi Therapeutics Drug Product Offered
11.6.3 Dynavax Technologies Antisense and RNAi Therapeutics Drug Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Dynavax Technologies Main Business Overview
11.6.5 Dynavax Technologies Latest Developments
11.7 Kastle therapeutics
11.7.1 Kastle therapeutics Company Information
11.7.2 Kastle therapeutics Antisense and RNAi Therapeutics Drug Product Offered
11.7.3 Kastle therapeutics Antisense and RNAi Therapeutics Drug Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Kastle therapeutics Main Business Overview
11.7.5 Kastle therapeutics Latest Developments
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Information
11.8.2 Akcea Therapeutics Antisense and RNAi Therapeutics Drug Product Offered
11.8.3 Akcea Therapeutics Antisense and RNAi Therapeutics Drug Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Akcea Therapeutics Main Business Overview
11.8.5 Akcea Therapeutics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Antisense and RNAi Therapeutics Drug Market Size (2021-2032)
2.1.2 Antisense and RNAi Therapeutics Drug Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Antisense and RNAi Therapeutics Drug by Country/Region (2021, 2025 & 2032)
2.2 Antisense and RNAi Therapeutics Drug Segment by Type
2.2.1 Antisense Oligonucleotide
2.2.2 Aptamer
2.2.3 Other
2.2.4 Antisense and RNAi Therapeutics Drug Market Size by Type
2.2.4.1 Antisense and RNAi Therapeutics Drug Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Antisense and RNAi Therapeutics Drug Market Size Market Share by Type (2021-2026)
2.3 Antisense and RNAi Therapeutics Drug Segment by Application
2.3.1 Neuromuscular Diseases
2.3.2 ATTR
2.3.3 Hepatic VOD
2.3.4 Other
2.3.5 Antisense and RNAi Therapeutics Drug Market Size by Application
2.3.5.1 Antisense and RNAi Therapeutics Drug Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.5.2 Global Antisense and RNAi Therapeutics Drug Market Size Market Share by Application (2021-2026)
3 ANTISENSE AND RNAI THERAPEUTICS DRUG MARKET SIZE BY PLAYER
3.1 Antisense and RNAi Therapeutics Drug Market Size Market Share by Player
3.1.1 Global Antisense and RNAi Therapeutics Drug Revenue by Player (2021-2026)
3.1.2 Global Antisense and RNAi Therapeutics Drug Revenue Market Share by Player (2021-2026)
3.2 Global Antisense and RNAi Therapeutics Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ANTISENSE AND RNAI THERAPEUTICS DRUG BY REGION
4.1 Antisense and RNAi Therapeutics Drug Market Size by Region (2021-2026)
4.2 Global Antisense and RNAi Therapeutics Drug Annual Revenue by Country/Region (2021-2026)
4.3 Americas Antisense and RNAi Therapeutics Drug Market Size Growth (2021-2026)
4.4 APAC Antisense and RNAi Therapeutics Drug Market Size Growth (2021-2026)
4.5 Europe Antisense and RNAi Therapeutics Drug Market Size Growth (2021-2026)
4.6 Middle East & Africa Antisense and RNAi Therapeutics Drug Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Antisense and RNAi Therapeutics Drug Market Size by Country (2021-2026)
5.2 Americas Antisense and RNAi Therapeutics Drug Market Size by Type (2021-2026)
5.3 Americas Antisense and RNAi Therapeutics Drug Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antisense and RNAi Therapeutics Drug Market Size by Region (2021-2026)
6.2 APAC Antisense and RNAi Therapeutics Drug Market Size by Type (2021-2026)
6.3 APAC Antisense and RNAi Therapeutics Drug Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Antisense and RNAi Therapeutics Drug Market Size by Country (2021-2026)
7.2 Europe Antisense and RNAi Therapeutics Drug Market Size by Type (2021-2026)
7.3 Europe Antisense and RNAi Therapeutics Drug Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Antisense and RNAi Therapeutics Drug by Region (2021-2026)
8.2 Middle East & Africa Antisense and RNAi Therapeutics Drug Market Size by Type (2021-2026)
8.3 Middle East & Africa Antisense and RNAi Therapeutics Drug Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ANTISENSE AND RNAI THERAPEUTICS DRUG MARKET FORECAST
10.1 Global Antisense and RNAi Therapeutics Drug Forecast by Region (2027-2032)
10.1.1 Global Antisense and RNAi Therapeutics Drug Forecast by Region (2027-2032)
10.1.2 Americas Antisense and RNAi Therapeutics Drug Forecast
10.1.3 APAC Antisense and RNAi Therapeutics Drug Forecast
10.1.4 Europe Antisense and RNAi Therapeutics Drug Forecast
10.1.5 Middle East & Africa Antisense and RNAi Therapeutics Drug Forecast
10.2 Americas Antisense and RNAi Therapeutics Drug Forecast by Country (2027-2032)
10.2.1 United States Market Antisense and RNAi Therapeutics Drug Forecast
10.2.2 Canada Market Antisense and RNAi Therapeutics Drug Forecast
10.2.3 Mexico Market Antisense and RNAi Therapeutics Drug Forecast
10.2.4 Brazil Market Antisense and RNAi Therapeutics Drug Forecast
10.3 APAC Antisense and RNAi Therapeutics Drug Forecast by Region (2027-2032)
10.3.1 China Antisense and RNAi Therapeutics Drug Market Forecast
10.3.2 Japan Market Antisense and RNAi Therapeutics Drug Forecast
10.3.3 Korea Market Antisense and RNAi Therapeutics Drug Forecast
10.3.4 Southeast Asia Market Antisense and RNAi Therapeutics Drug Forecast
10.3.5 India Market Antisense and RNAi Therapeutics Drug Forecast
10.3.6 Australia Market Antisense and RNAi Therapeutics Drug Forecast
10.4 Europe Antisense and RNAi Therapeutics Drug Forecast by Country (2027-2032)
10.4.1 Germany Market Antisense and RNAi Therapeutics Drug Forecast
10.4.2 France Market Antisense and RNAi Therapeutics Drug Forecast
10.4.3 UK Market Antisense and RNAi Therapeutics Drug Forecast
10.4.4 Italy Market Antisense and RNAi Therapeutics Drug Forecast
10.4.5 Russia Market Antisense and RNAi Therapeutics Drug Forecast
10.5 Middle East & Africa Antisense and RNAi Therapeutics Drug Forecast by Region (2027-2032)
10.5.1 Egypt Market Antisense and RNAi Therapeutics Drug Forecast
10.5.2 South Africa Market Antisense and RNAi Therapeutics Drug Forecast
10.5.3 Israel Market Antisense and RNAi Therapeutics Drug Forecast
10.5.4 Turkey Market Antisense and RNAi Therapeutics Drug Forecast
10.6 Global Antisense and RNAi Therapeutics Drug Forecast by Type (2027-2032)
10.7 Global Antisense and RNAi Therapeutics Drug Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Antisense and RNAi Therapeutics Drug Forecast
11 KEY PLAYERS ANALYSIS
11.1 Biogen
11.1.1 Biogen Company Information
11.1.2 Biogen Antisense and RNAi Therapeutics Drug Product Offered
11.1.3 Biogen Antisense and RNAi Therapeutics Drug Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Biogen Main Business Overview
11.1.5 Biogen Latest Developments
11.2 Sarepta Therapeutics
11.2.1 Sarepta Therapeutics Company Information
11.2.2 Sarepta Therapeutics Antisense and RNAi Therapeutics Drug Product Offered
11.2.3 Sarepta Therapeutics Antisense and RNAi Therapeutics Drug Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Sarepta Therapeutics Main Business Overview
11.2.5 Sarepta Therapeutics Latest Developments
11.3 Jazz Pharmaceuticals
11.3.1 Jazz Pharmaceuticals Company Information
11.3.2 Jazz Pharmaceuticals Antisense and RNAi Therapeutics Drug Product Offered
11.3.3 Jazz Pharmaceuticals Antisense and RNAi Therapeutics Drug Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Jazz Pharmaceuticals Main Business Overview
11.3.5 Jazz Pharmaceuticals Latest Developments
11.4 Bausch & Lomb
11.4.1 Bausch & Lomb Company Information
11.4.2 Bausch & Lomb Antisense and RNAi Therapeutics Drug Product Offered
11.4.3 Bausch & Lomb Antisense and RNAi Therapeutics Drug Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Bausch & Lomb Main Business Overview
11.4.5 Bausch & Lomb Latest Developments
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Information
11.5.2 Alnylam Pharmaceuticals Antisense and RNAi Therapeutics Drug Product Offered
11.5.3 Alnylam Pharmaceuticals Antisense and RNAi Therapeutics Drug Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Alnylam Pharmaceuticals Main Business Overview
11.5.5 Alnylam Pharmaceuticals Latest Developments
11.6 Dynavax Technologies
11.6.1 Dynavax Technologies Company Information
11.6.2 Dynavax Technologies Antisense and RNAi Therapeutics Drug Product Offered
11.6.3 Dynavax Technologies Antisense and RNAi Therapeutics Drug Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Dynavax Technologies Main Business Overview
11.6.5 Dynavax Technologies Latest Developments
11.7 Kastle therapeutics
11.7.1 Kastle therapeutics Company Information
11.7.2 Kastle therapeutics Antisense and RNAi Therapeutics Drug Product Offered
11.7.3 Kastle therapeutics Antisense and RNAi Therapeutics Drug Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Kastle therapeutics Main Business Overview
11.7.5 Kastle therapeutics Latest Developments
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Information
11.8.2 Akcea Therapeutics Antisense and RNAi Therapeutics Drug Product Offered
11.8.3 Akcea Therapeutics Antisense and RNAi Therapeutics Drug Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Akcea Therapeutics Main Business Overview
11.8.5 Akcea Therapeutics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Antisense and RNAi Therapeutics Drug Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Antisense and RNAi Therapeutics Drug Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Antisense Oligonucleotide
Table 4. Major Players of Aptamer
Table 5. Major Players of Other
Table 6. Antisense and RNAi Therapeutics Drug Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Antisense and RNAi Therapeutics Drug Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Antisense and RNAi Therapeutics Drug Market Size Market Share by Type (2021-2026)
Table 9. Antisense and RNAi Therapeutics Drug Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Antisense and RNAi Therapeutics Drug Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Antisense and RNAi Therapeutics Drug Market Size Market Share by Application (2021-2026)
Table 12. Global Antisense and RNAi Therapeutics Drug Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Antisense and RNAi Therapeutics Drug Revenue Market Share by Player (2021-2026)
Table 14. Antisense and RNAi Therapeutics Drug Key Players Head office and Products Offered
Table 15. Antisense and RNAi Therapeutics Drug Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Antisense and RNAi Therapeutics Drug Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Antisense and RNAi Therapeutics Drug Market Size Market Share by Region (2021-2026)
Table 20. Global Antisense and RNAi Therapeutics Drug Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Antisense and RNAi Therapeutics Drug Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Antisense and RNAi Therapeutics Drug Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Antisense and RNAi Therapeutics Drug Market Size Market Share by Country (2021-2026)
Table 24. Americas Antisense and RNAi Therapeutics Drug Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Antisense and RNAi Therapeutics Drug Market Size Market Share by Type (2021-2026)
Table 26. Americas Antisense and RNAi Therapeutics Drug Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Antisense and RNAi Therapeutics Drug Market Size Market Share by Application (2021-2026)
Table 28. APAC Antisense and RNAi Therapeutics Drug Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Antisense and RNAi Therapeutics Drug Market Size Market Share by Region (2021-2026)
Table 30. APAC Antisense and RNAi Therapeutics Drug Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Antisense and RNAi Therapeutics Drug Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Antisense and RNAi Therapeutics Drug Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Antisense and RNAi Therapeutics Drug Market Size Market Share by Country (2021-2026)
Table 34. Europe Antisense and RNAi Therapeutics Drug Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Antisense and RNAi Therapeutics Drug Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Antisense and RNAi Therapeutics Drug Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Antisense and RNAi Therapeutics Drug Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Antisense and RNAi Therapeutics Drug Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Antisense and RNAi Therapeutics Drug
Table 40. Key Market Challenges & Risks of Antisense and RNAi Therapeutics Drug
Table 41. Key Industry Trends of Antisense and RNAi Therapeutics Drug
Table 42. Global Antisense and RNAi Therapeutics Drug Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Antisense and RNAi Therapeutics Drug Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Antisense and RNAi Therapeutics Drug Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Antisense and RNAi Therapeutics Drug Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. Biogen Details, Company Type, Antisense and RNAi Therapeutics Drug Area Served and Its Competitors
Table 47. Biogen Antisense and RNAi Therapeutics Drug Product Offered
Table 48. Biogen Antisense and RNAi Therapeutics Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. Biogen Main Business
Table 50. Biogen Latest Developments
Table 51. Sarepta Therapeutics Details, Company Type, Antisense and RNAi Therapeutics Drug Area Served and Its Competitors
Table 52. Sarepta Therapeutics Antisense and RNAi Therapeutics Drug Product Offered
Table 53. Sarepta Therapeutics Antisense and RNAi Therapeutics Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Sarepta Therapeutics Main Business
Table 55. Sarepta Therapeutics Latest Developments
Table 56. Jazz Pharmaceuticals Details, Company Type, Antisense and RNAi Therapeutics Drug Area Served and Its Competitors
Table 57. Jazz Pharmaceuticals Antisense and RNAi Therapeutics Drug Product Offered
Table 58. Jazz Pharmaceuticals Antisense and RNAi Therapeutics Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Jazz Pharmaceuticals Main Business
Table 60. Jazz Pharmaceuticals Latest Developments
Table 61. Bausch & Lomb Details, Company Type, Antisense and RNAi Therapeutics Drug Area Served and Its Competitors
Table 62. Bausch & Lomb Antisense and RNAi Therapeutics Drug Product Offered
Table 63. Bausch & Lomb Antisense and RNAi Therapeutics Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Bausch & Lomb Main Business
Table 65. Bausch & Lomb Latest Developments
Table 66. Alnylam Pharmaceuticals Details, Company Type, Antisense and RNAi Therapeutics Drug Area Served and Its Competitors
Table 67. Alnylam Pharmaceuticals Antisense and RNAi Therapeutics Drug Product Offered
Table 68. Alnylam Pharmaceuticals Antisense and RNAi Therapeutics Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Alnylam Pharmaceuticals Main Business
Table 70. Alnylam Pharmaceuticals Latest Developments
Table 71. Dynavax Technologies Details, Company Type, Antisense and RNAi Therapeutics Drug Area Served and Its Competitors
Table 72. Dynavax Technologies Antisense and RNAi Therapeutics Drug Product Offered
Table 73. Dynavax Technologies Antisense and RNAi Therapeutics Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Dynavax Technologies Main Business
Table 75. Dynavax Technologies Latest Developments
Table 76. Kastle therapeutics Details, Company Type, Antisense and RNAi Therapeutics Drug Area Served and Its Competitors
Table 77. Kastle therapeutics Antisense and RNAi Therapeutics Drug Product Offered
Table 78. Kastle therapeutics Antisense and RNAi Therapeutics Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Kastle therapeutics Main Business
Table 80. Kastle therapeutics Latest Developments
Table 81. Akcea Therapeutics Details, Company Type, Antisense and RNAi Therapeutics Drug Area Served and Its Competitors
Table 82. Akcea Therapeutics Antisense and RNAi Therapeutics Drug Product Offered
Table 83. Akcea Therapeutics Antisense and RNAi Therapeutics Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Akcea Therapeutics Main Business
Table 85. Akcea Therapeutics Latest Developments
Table 1. Antisense and RNAi Therapeutics Drug Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Antisense and RNAi Therapeutics Drug Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Antisense Oligonucleotide
Table 4. Major Players of Aptamer
Table 5. Major Players of Other
Table 6. Antisense and RNAi Therapeutics Drug Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Antisense and RNAi Therapeutics Drug Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Antisense and RNAi Therapeutics Drug Market Size Market Share by Type (2021-2026)
Table 9. Antisense and RNAi Therapeutics Drug Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Antisense and RNAi Therapeutics Drug Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Antisense and RNAi Therapeutics Drug Market Size Market Share by Application (2021-2026)
Table 12. Global Antisense and RNAi Therapeutics Drug Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Antisense and RNAi Therapeutics Drug Revenue Market Share by Player (2021-2026)
Table 14. Antisense and RNAi Therapeutics Drug Key Players Head office and Products Offered
Table 15. Antisense and RNAi Therapeutics Drug Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Antisense and RNAi Therapeutics Drug Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Antisense and RNAi Therapeutics Drug Market Size Market Share by Region (2021-2026)
Table 20. Global Antisense and RNAi Therapeutics Drug Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Antisense and RNAi Therapeutics Drug Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Antisense and RNAi Therapeutics Drug Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Antisense and RNAi Therapeutics Drug Market Size Market Share by Country (2021-2026)
Table 24. Americas Antisense and RNAi Therapeutics Drug Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Antisense and RNAi Therapeutics Drug Market Size Market Share by Type (2021-2026)
Table 26. Americas Antisense and RNAi Therapeutics Drug Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Antisense and RNAi Therapeutics Drug Market Size Market Share by Application (2021-2026)
Table 28. APAC Antisense and RNAi Therapeutics Drug Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Antisense and RNAi Therapeutics Drug Market Size Market Share by Region (2021-2026)
Table 30. APAC Antisense and RNAi Therapeutics Drug Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Antisense and RNAi Therapeutics Drug Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Antisense and RNAi Therapeutics Drug Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Antisense and RNAi Therapeutics Drug Market Size Market Share by Country (2021-2026)
Table 34. Europe Antisense and RNAi Therapeutics Drug Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Antisense and RNAi Therapeutics Drug Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Antisense and RNAi Therapeutics Drug Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Antisense and RNAi Therapeutics Drug Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Antisense and RNAi Therapeutics Drug Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Antisense and RNAi Therapeutics Drug
Table 40. Key Market Challenges & Risks of Antisense and RNAi Therapeutics Drug
Table 41. Key Industry Trends of Antisense and RNAi Therapeutics Drug
Table 42. Global Antisense and RNAi Therapeutics Drug Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Antisense and RNAi Therapeutics Drug Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Antisense and RNAi Therapeutics Drug Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Antisense and RNAi Therapeutics Drug Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. Biogen Details, Company Type, Antisense and RNAi Therapeutics Drug Area Served and Its Competitors
Table 47. Biogen Antisense and RNAi Therapeutics Drug Product Offered
Table 48. Biogen Antisense and RNAi Therapeutics Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. Biogen Main Business
Table 50. Biogen Latest Developments
Table 51. Sarepta Therapeutics Details, Company Type, Antisense and RNAi Therapeutics Drug Area Served and Its Competitors
Table 52. Sarepta Therapeutics Antisense and RNAi Therapeutics Drug Product Offered
Table 53. Sarepta Therapeutics Antisense and RNAi Therapeutics Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Sarepta Therapeutics Main Business
Table 55. Sarepta Therapeutics Latest Developments
Table 56. Jazz Pharmaceuticals Details, Company Type, Antisense and RNAi Therapeutics Drug Area Served and Its Competitors
Table 57. Jazz Pharmaceuticals Antisense and RNAi Therapeutics Drug Product Offered
Table 58. Jazz Pharmaceuticals Antisense and RNAi Therapeutics Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Jazz Pharmaceuticals Main Business
Table 60. Jazz Pharmaceuticals Latest Developments
Table 61. Bausch & Lomb Details, Company Type, Antisense and RNAi Therapeutics Drug Area Served and Its Competitors
Table 62. Bausch & Lomb Antisense and RNAi Therapeutics Drug Product Offered
Table 63. Bausch & Lomb Antisense and RNAi Therapeutics Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Bausch & Lomb Main Business
Table 65. Bausch & Lomb Latest Developments
Table 66. Alnylam Pharmaceuticals Details, Company Type, Antisense and RNAi Therapeutics Drug Area Served and Its Competitors
Table 67. Alnylam Pharmaceuticals Antisense and RNAi Therapeutics Drug Product Offered
Table 68. Alnylam Pharmaceuticals Antisense and RNAi Therapeutics Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Alnylam Pharmaceuticals Main Business
Table 70. Alnylam Pharmaceuticals Latest Developments
Table 71. Dynavax Technologies Details, Company Type, Antisense and RNAi Therapeutics Drug Area Served and Its Competitors
Table 72. Dynavax Technologies Antisense and RNAi Therapeutics Drug Product Offered
Table 73. Dynavax Technologies Antisense and RNAi Therapeutics Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Dynavax Technologies Main Business
Table 75. Dynavax Technologies Latest Developments
Table 76. Kastle therapeutics Details, Company Type, Antisense and RNAi Therapeutics Drug Area Served and Its Competitors
Table 77. Kastle therapeutics Antisense and RNAi Therapeutics Drug Product Offered
Table 78. Kastle therapeutics Antisense and RNAi Therapeutics Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Kastle therapeutics Main Business
Table 80. Kastle therapeutics Latest Developments
Table 81. Akcea Therapeutics Details, Company Type, Antisense and RNAi Therapeutics Drug Area Served and Its Competitors
Table 82. Akcea Therapeutics Antisense and RNAi Therapeutics Drug Product Offered
Table 83. Akcea Therapeutics Antisense and RNAi Therapeutics Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Akcea Therapeutics Main Business
Table 85. Akcea Therapeutics Latest Developments
LIST OF FIGURES
Figure 1. Antisense and RNAi Therapeutics Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Antisense and RNAi Therapeutics Drug Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Antisense and RNAi Therapeutics Drug Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Antisense and RNAi Therapeutics Drug Sales Market Share by Country/Region (2025)
Figure 8. Antisense and RNAi Therapeutics Drug Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Antisense and RNAi Therapeutics Drug Market Size Market Share by Type in 2025
Figure 10. Antisense and RNAi Therapeutics Drug in Neuromuscular Diseases
Figure 11. Global Antisense and RNAi Therapeutics Drug Market: Neuromuscular Diseases (2021-2026) & ($ millions)
Figure 12. Antisense and RNAi Therapeutics Drug in ATTR
Figure 13. Global Antisense and RNAi Therapeutics Drug Market: ATTR (2021-2026) & ($ millions)
Figure 14. Antisense and RNAi Therapeutics Drug in Hepatic VOD
Figure 15. Global Antisense and RNAi Therapeutics Drug Market: Hepatic VOD (2021-2026) & ($ millions)
Figure 16. Antisense and RNAi Therapeutics Drug in Other
Figure 17. Global Antisense and RNAi Therapeutics Drug Market: Other (2021-2026) & ($ millions)
Figure 18. Global Antisense and RNAi Therapeutics Drug Market Size Market Share by Application in 2025
Figure 19. Global Antisense and RNAi Therapeutics Drug Revenue Market Share by Player in 2025
Figure 20. Global Antisense and RNAi Therapeutics Drug Market Size Market Share by Region (2021-2026)
Figure 21. Americas Antisense and RNAi Therapeutics Drug Market Size 2021-2026 ($ millions)
Figure 22. APAC Antisense and RNAi Therapeutics Drug Market Size 2021-2026 ($ millions)
Figure 23. Europe Antisense and RNAi Therapeutics Drug Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Antisense and RNAi Therapeutics Drug Market Size 2021-2026 ($ millions)
Figure 25. Americas Antisense and RNAi Therapeutics Drug Value Market Share by Country in 2025
Figure 26. United States Antisense and RNAi Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Antisense and RNAi Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Antisense and RNAi Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Antisense and RNAi Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Antisense and RNAi Therapeutics Drug Market Size Market Share by Region in 2025
Figure 31. APAC Antisense and RNAi Therapeutics Drug Market Size Market Share by Type (2021-2026)
Figure 32. APAC Antisense and RNAi Therapeutics Drug Market Size Market Share by Application (2021-2026)
Figure 33. China Antisense and RNAi Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Antisense and RNAi Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Antisense and RNAi Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Antisense and RNAi Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 37. India Antisense and RNAi Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Antisense and RNAi Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Antisense and RNAi Therapeutics Drug Market Size Market Share by Country in 2025
Figure 40. Europe Antisense and RNAi Therapeutics Drug Market Size Market Share by Type (2021-2026)
Figure 41. Europe Antisense and RNAi Therapeutics Drug Market Size Market Share by Application (2021-2026)
Figure 42. Germany Antisense and RNAi Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 43. France Antisense and RNAi Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Antisense and RNAi Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Antisense and RNAi Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Antisense and RNAi Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Antisense and RNAi Therapeutics Drug Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Antisense and RNAi Therapeutics Drug Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Antisense and RNAi Therapeutics Drug Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Antisense and RNAi Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Antisense and RNAi Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Antisense and RNAi Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Antisense and RNAi Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Antisense and RNAi Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Antisense and RNAi Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 56. APAC Antisense and RNAi Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 57. Europe Antisense and RNAi Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Antisense and RNAi Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 59. United States Antisense and RNAi Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 60. Canada Antisense and RNAi Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 61. Mexico Antisense and RNAi Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 62. Brazil Antisense and RNAi Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 63. China Antisense and RNAi Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 64. Japan Antisense and RNAi Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 65. Korea Antisense and RNAi Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Antisense and RNAi Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 67. India Antisense and RNAi Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 68. Australia Antisense and RNAi Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 69. Germany Antisense and RNAi Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 70. France Antisense and RNAi Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 71. UK Antisense and RNAi Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 72. Italy Antisense and RNAi Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 73. Russia Antisense and RNAi Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 74. Egypt Antisense and RNAi Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 75. South Africa Antisense and RNAi Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 76. Israel Antisense and RNAi Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 77. Turkey Antisense and RNAi Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 78. Global Antisense and RNAi Therapeutics Drug Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Antisense and RNAi Therapeutics Drug Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Antisense and RNAi Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 1. Antisense and RNAi Therapeutics Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Antisense and RNAi Therapeutics Drug Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Antisense and RNAi Therapeutics Drug Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Antisense and RNAi Therapeutics Drug Sales Market Share by Country/Region (2025)
Figure 8. Antisense and RNAi Therapeutics Drug Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Antisense and RNAi Therapeutics Drug Market Size Market Share by Type in 2025
Figure 10. Antisense and RNAi Therapeutics Drug in Neuromuscular Diseases
Figure 11. Global Antisense and RNAi Therapeutics Drug Market: Neuromuscular Diseases (2021-2026) & ($ millions)
Figure 12. Antisense and RNAi Therapeutics Drug in ATTR
Figure 13. Global Antisense and RNAi Therapeutics Drug Market: ATTR (2021-2026) & ($ millions)
Figure 14. Antisense and RNAi Therapeutics Drug in Hepatic VOD
Figure 15. Global Antisense and RNAi Therapeutics Drug Market: Hepatic VOD (2021-2026) & ($ millions)
Figure 16. Antisense and RNAi Therapeutics Drug in Other
Figure 17. Global Antisense and RNAi Therapeutics Drug Market: Other (2021-2026) & ($ millions)
Figure 18. Global Antisense and RNAi Therapeutics Drug Market Size Market Share by Application in 2025
Figure 19. Global Antisense and RNAi Therapeutics Drug Revenue Market Share by Player in 2025
Figure 20. Global Antisense and RNAi Therapeutics Drug Market Size Market Share by Region (2021-2026)
Figure 21. Americas Antisense and RNAi Therapeutics Drug Market Size 2021-2026 ($ millions)
Figure 22. APAC Antisense and RNAi Therapeutics Drug Market Size 2021-2026 ($ millions)
Figure 23. Europe Antisense and RNAi Therapeutics Drug Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Antisense and RNAi Therapeutics Drug Market Size 2021-2026 ($ millions)
Figure 25. Americas Antisense and RNAi Therapeutics Drug Value Market Share by Country in 2025
Figure 26. United States Antisense and RNAi Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Antisense and RNAi Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Antisense and RNAi Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Antisense and RNAi Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Antisense and RNAi Therapeutics Drug Market Size Market Share by Region in 2025
Figure 31. APAC Antisense and RNAi Therapeutics Drug Market Size Market Share by Type (2021-2026)
Figure 32. APAC Antisense and RNAi Therapeutics Drug Market Size Market Share by Application (2021-2026)
Figure 33. China Antisense and RNAi Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Antisense and RNAi Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Antisense and RNAi Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Antisense and RNAi Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 37. India Antisense and RNAi Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Antisense and RNAi Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Antisense and RNAi Therapeutics Drug Market Size Market Share by Country in 2025
Figure 40. Europe Antisense and RNAi Therapeutics Drug Market Size Market Share by Type (2021-2026)
Figure 41. Europe Antisense and RNAi Therapeutics Drug Market Size Market Share by Application (2021-2026)
Figure 42. Germany Antisense and RNAi Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 43. France Antisense and RNAi Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Antisense and RNAi Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Antisense and RNAi Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Antisense and RNAi Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Antisense and RNAi Therapeutics Drug Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Antisense and RNAi Therapeutics Drug Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Antisense and RNAi Therapeutics Drug Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Antisense and RNAi Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Antisense and RNAi Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Antisense and RNAi Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Antisense and RNAi Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Antisense and RNAi Therapeutics Drug Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Antisense and RNAi Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 56. APAC Antisense and RNAi Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 57. Europe Antisense and RNAi Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Antisense and RNAi Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 59. United States Antisense and RNAi Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 60. Canada Antisense and RNAi Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 61. Mexico Antisense and RNAi Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 62. Brazil Antisense and RNAi Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 63. China Antisense and RNAi Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 64. Japan Antisense and RNAi Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 65. Korea Antisense and RNAi Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Antisense and RNAi Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 67. India Antisense and RNAi Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 68. Australia Antisense and RNAi Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 69. Germany Antisense and RNAi Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 70. France Antisense and RNAi Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 71. UK Antisense and RNAi Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 72. Italy Antisense and RNAi Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 73. Russia Antisense and RNAi Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 74. Egypt Antisense and RNAi Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 75. South Africa Antisense and RNAi Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 76. Israel Antisense and RNAi Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 77. Turkey Antisense and RNAi Therapeutics Drug Market Size 2027-2032 ($ millions)
Figure 78. Global Antisense and RNAi Therapeutics Drug Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Antisense and RNAi Therapeutics Drug Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Antisense and RNAi Therapeutics Drug Market Size 2027-2032 ($ millions)
